共 50 条
Adalimumab as treatment for neurosarcoidosis: A case series
被引:0
|作者:
Shen, Jeffrey
[1
]
Sugita, Megumi
[2
]
Linares-Lopez, Andrea
[2
]
Shah, Suma
[3
]
Eckstein, Christopher
[3
]
Lackey, Elijah
[3
,4
]
机构:
[1] Duke Univ Hosp, Dept Rheumatol, Durham, NC USA
[2] Duke Univ Hosp, Dept Neurol, Durham, NC USA
[3] Duke Univ Hosp, Dept MS & Neuroimmunol, Durham, NC USA
[4] Duke Univ Hosp, 2301 Erwin Rd, Durham, NC 27705 USA
关键词:
Neurosarcoidosis;
Neuroimmunology;
Adalimumab;
TNF-alpha inhibitors;
SARCOIDOSIS;
INFLIXIMAB;
D O I:
10.1016/j.jns.2024.123018
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
Sarcoidosis is a disease characterized by non-caseating granulomas that can involve the central nervous system as neurosarcoidosis. This challenging disease is currently managed with high dose steroids, and sometimes the addition of infliximab. Other TNA-alpha inhibitors have not been studied as rigorously. We discovered ten neurosarcoidosis patients who were on an alternative TNA-alpha inhibitor, adalimumab. Eight patients had a positive response clinically and radiographically to adalimumab.
引用
收藏
页数:5
相关论文